SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-23-125007
Filing Date
2023-12-11
Accepted
2023-12-11 16:16:31
Documents
1
Group Members
ALPHABET HOLDINGS LLCALPHABET INC.GV 2017 GP, L.L.C.GV 2017 GP, L.P.GV 2019 GP, L.L.C.GV 2019 GP, L.P.GV 2019, L.P.GV 2023 GP, L.L.C.GV 2023 GP, L.P.GV 2023, L.P.VERILY LIFE SCIENCES LLCXXVI HOLDINGS INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2332458d1_sc13ga.htm SC 13G/A 287093
  Complete submission text file 0001104659-23-125007.txt   288987
Mailing Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043
Business Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043 650-335-5278
GV 2017, L.P. (Filed by) CIK: 0001733340 (see all company filings)

IRS No.: 352587854 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Subject) CIK: 0001840574 (see all company filings)

IRS No.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92605 | Film No.: 231478331
SIC: 2834 Pharmaceutical Preparations